pemirolast
Sign in to saveAlso known as Alamast®, Alegysal®, BMY-26517, Pemirolastum, Pemirox
Pemirolast (INN) is a mast cell stabilizer used as an anti-allergic drug therapy. It is marketed under the tradenames Alegysal and Alamast.
Research
67 papers- Pemirolast.2006
- Pemirolast reduces cisplatin-induced kaolin intake in rats.European journal of pharmacology · 2011
- Pemirolast potassium 0.1% ophthalmic solution is an effective treatment for allergic conjunctivitis: a pooled analysis of two prospective, randomized, double-masked, placebo-controlled, phase III studies.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2002
- In vivo and in vitro Evaluation of in situ Gel Formulation of Pemirolast Potassium in Allergic Conjunctivitis.Drug design, development and therapy · 2021
- Suppressive activity of pemirolast potassium, an antiallergic drug, on glomerulonephritis. Studies in glomerulonephritis model rats and in patients with chronic glomerulonephritis concurrently affected by allergic rhinitis.Arzneimittel-Forschung · 2008
via PubMed
Wikidata facts
- Mass
- 228.075959
Show 2 more facts
- chemical formula
- C₁₀H₈N₆O
- canonical SMILES
- CC1=CC=CN2C1=NC=C(C2=O)C3=NNN=N3
Sources (2)
via Wikidata · CC0
~1 min read
Article
2 sectionsContents
- References
- External links
Pemirolast (INN) is a mast cell stabilizer used as an anti-allergic drug therapy. It is marketed under the tradenames Alegysal and Alamast.
Clinical trials studying treatments for allergic conjunctivitis have found that an ophthalmic solution containing levocabastine with pemirolast potassium may be more effective in alleviating symptoms than levocabastine alone.
Connections
asthma
Entity
allergy
Entity
digital object identifier
Entity
chemical formula
Entity
molar mass
Entity
Q180686
Entity
antidepressant
Entity
CAS Registry Number
Entity
Q229883
Entity
PubChem
Entity
Anatomical Therapeutic Chemical Classification System
Entity
amitriptyline
Entity
cetirizine
Entity
clinical trial
Entity
simplified molecular input line entry specification
Entity
histamine antagonist
Entity
loratadine
Entity
isoniazid
Entity
diphenhydramine
Entity
IUPAC nomenclature of chemistry
Entity